We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
(-20%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$22.7M |
| 2 |
Centene
CNC
|
+$20M |
| 3 |
Ingersoll Rand
IR
|
+$18.4M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$16.8M |
| 5 |
Digital Realty Trust
DLR
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.6M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$34.9M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$27M |
| 4 |
Netflix
NFLX
|
+$25.9M |
| 5 |
Howmet Aerospace
HWM
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.47% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Ardelyx
ARDX
$982M
| $550K | ﹤0.01% |
96,797
+22,575
| +30% | +$153K |
|
2127
Rocket Pharmaceuticals
RCKT
$389M
| $550K | ﹤0.01% |
39,442
+1,949
| +5% | +$38.6K |
|
2128
Berkshire Hathaway Class A
BRK.A
$1.14T
| $544K | ﹤0.01% |
2
+1
| +100% | +$319K |
|
2129
GrafTech
EAF
$207M
| $543K | ﹤0.01% |
6,686
+2,191
| +49% | +$211K |
|
2130
Simulations Plus
SLP
$371M
| $540K | ﹤0.01% |
15,477
+14
| +0.1% | +$467 |
|
2131
Amneal Pharmaceuticals
AMRX
$5.8B
| $539K | ﹤0.01% |
155,006
+7,987
| +5% | +$33.8K |
|
2132
Snap
SNAP
$9.03B
| $538K | ﹤0.01% |
45,241
+5,384
| +14% | +$82.6K |
|
|
SRG
2133
Seritage Growth Properties
SRG
$136M
| $538K | ﹤0.01% |
59,010
+5,000
| +9% | +$156K |
|
2134
The Bancorp
TBBK
$2.81B
| $536K | ﹤0.01% |
88,284
+9,428
| +12% | +$101K |
|
2135
Miller Industries
MLR
$609M
| $534K | ﹤0.01% |
18,866
+1,300
| +7% | +$42K |
|
|
TPIC
2136
DELISTED
TPI Composites
TPIC
| $533K | ﹤0.01% |
36,036
+1,600
| +5% | +$31.5K |
|
2137
Mercer International
MERC
$35.1M
| $532K | ﹤0.01% |
73,542
+2,378
| +3% | +$23.8K |
|
2138
Farmers National Banc Corp
FMNB
$928M
| $530K | ﹤0.01% |
45,561
+5,750
| +14% | +$85.1K |
|
|
GHL
2139
DELISTED
Greenhill & Co., Inc.
GHL
| $528K | ﹤0.01% |
53,653
+1,282
| +2% | +$18.7K |
|
2140
Krystal Biotech
KRYS
$9.66B
| $526K | ﹤0.01% |
12,175
+867
| +8% | +$45.3K |
|
|
GTHX
2141
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $526K | ﹤0.01% |
47,716
+2,192
| +5% | +$40.9K |
|
2142
Live Oak Bancshares
LOB
$1.94B
| $525K | ﹤0.01% |
42,125
+1,135
| +3% | +$18K |
|
2143
The RealReal
REAL
$1.5B
| $525K | ﹤0.01% |
74,860
+52,118
| +229% | +$710K |
|
2144
Rhythm Pharmaceuticals
RYTM
$7.94B
| $525K | ﹤0.01% |
34,504
+2,109
| +7% | +$37.8K |
|
|
ATRS
2145
DELISTED
Antares Pharma, Inc.
ATRS
| $523K | ﹤0.01% |
221,650
-1,100
| -0.5% | -$3.74K |
|
|
AXNX
2146
DELISTED
Axonics, Inc. Common Stock
AXNX
| $522K | ﹤0.01% |
20,552
+2,994
| +17% | +$89K |
|
|
CAMP
2147
DELISTED
CalAmp Corp.
CAMP
| $521K | ﹤0.01% |
5,033
+78
| +2% | +$15.3K |
|
2148
First Bancorp
FNLC
$394M
| $516K | ﹤0.01% |
23,469
+7,100
| +43% | +$188K |
|
|
CAI
2149
DELISTED
CAI International, Inc.
CAI
| $515K | ﹤0.01% |
36,395
+3,354
| +10% | +$80.7K |
|
|
ALTA
2150
DELISTED
Altabancorp
ALTA
| $514K | ﹤0.01% |
26,539
+2,050
| +8% | +$51.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2020 Portfolio in Review
As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
- RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
- RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
- RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
- RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
- RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
- RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.